JP2024534567A5 - - Google Patents
Info
- Publication number
- JP2024534567A5 JP2024534567A5 JP2024518351A JP2024518351A JP2024534567A5 JP 2024534567 A5 JP2024534567 A5 JP 2024534567A5 JP 2024518351 A JP2024518351 A JP 2024518351A JP 2024518351 A JP2024518351 A JP 2024518351A JP 2024534567 A5 JP2024534567 A5 JP 2024534567A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- piperidyl
- pyridine
- pyridyl
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021120406 | 2021-09-24 | ||
| CNPCT/CN2021/120406 | 2021-09-24 | ||
| CN2022089033 | 2022-04-25 | ||
| CNPCT/CN2022/089033 | 2022-04-25 | ||
| PCT/EP2022/076306 WO2023046806A1 (en) | 2021-09-24 | 2022-09-22 | Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534567A JP2024534567A (ja) | 2024-09-20 |
| JP2024534567A5 true JP2024534567A5 (cg-RX-API-DMAC10.html) | 2025-09-26 |
Family
ID=83688579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518351A Pending JP2024534567A (ja) | 2021-09-24 | 2022-09-22 | 自己免疫疾患の処置のためのピラゾロ[3,4-b]ピリジン化合物 |
Country Status (16)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026515029A (ja) * | 2023-04-28 | 2026-05-13 | 成都思倍博医▲薬▼科技有限公司 | オキソピリド脂肪族環又は脂肪族複素環構造を含む化合物及びその医学的使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9643967B2 (en) * | 2013-12-13 | 2017-05-09 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors |
| EP4059934B1 (en) | 2016-09-09 | 2026-07-29 | Novartis AG | Compounds and compositions as inhibitors of endosomal toll-like receptors |
| JP2021507889A (ja) * | 2017-12-22 | 2021-02-25 | ノバルティス アーゲー | ピラゾロピペリジン誘導体の新規な使用 |
| WO2019220390A1 (en) | 2018-05-18 | 2019-11-21 | Novartis Ag | Crystalline forms of a tlr7/tlr8 inhibitor |
| CN112752755A (zh) * | 2018-09-27 | 2021-05-04 | 豪夫迈·罗氏有限公司 | 用于治疗自身免疫性疾病的杂环基化合物 |
| JP2023533807A (ja) * | 2020-07-14 | 2023-08-04 | エフ. ホフマン-ラ ロシュ アーゲー | 自己免疫疾患の処置のためのヒドロイソキノリン又はヒドロナフチリジン化合物 |
-
2022
- 2022-09-22 PE PE2024003046A patent/PE20250401A1/es unknown
- 2022-09-22 CR CR20240134A patent/CR20240134A/es unknown
- 2022-09-22 CA CA3228485A patent/CA3228485A1/en active Pending
- 2022-09-22 MX MX2024003444A patent/MX2024003444A/es unknown
- 2022-09-22 KR KR1020247009335A patent/KR20240065092A/ko active Pending
- 2022-09-22 AU AU2022351495A patent/AU2022351495A1/en active Pending
- 2022-09-22 PE PE2024000482A patent/PE20240815A1/es unknown
- 2022-09-22 JP JP2024518351A patent/JP2024534567A/ja active Pending
- 2022-09-22 EP EP22786353.7A patent/EP4405051B1/en active Active
- 2022-09-22 IL IL310443A patent/IL310443A/en unknown
- 2022-09-22 CN CN202280063841.XA patent/CN118076604A/zh active Pending
- 2022-09-22 WO PCT/EP2022/076306 patent/WO2023046806A1/en not_active Ceased
- 2022-09-22 AR ARP220102558A patent/AR127126A1/es unknown
- 2022-09-23 TW TW111136043A patent/TW202328129A/zh unknown
-
2024
- 2024-03-15 US US18/606,123 patent/US20240360126A1/en active Pending
- 2024-03-18 CL CL2024000791A patent/CL2024000791A1/es unknown
- 2024-03-19 CO CONC2024/0003401A patent/CO2024003401A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023266254B2 (en) | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway | |
| CN116368140A (zh) | 杂环glp-1激动剂 | |
| JP2025078673A (ja) | インダゾール系化合物及び関連使用方法 | |
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| JP2012503018A5 (cg-RX-API-DMAC10.html) | ||
| JP6117235B2 (ja) | Pi3kの活性または機能の阻害剤の使用 | |
| CA3139019A1 (en) | Amino quinazoline derivatives as p2x3 inhibitors | |
| AU2018390610A1 (en) | Amino indole compounds useful as TLR inhibitors | |
| JP2023539663A (ja) | 急速進行性線維肉腫タンパク質分解化合物及び関連する使用方法 | |
| JP2015510938A5 (cg-RX-API-DMAC10.html) | ||
| JP2012525395A5 (cg-RX-API-DMAC10.html) | ||
| US10526323B2 (en) | Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | |
| KR20030016283A (ko) | 뉴로키닌 수용체 길항제로서의1,3,8-트리아자-스피로[4.5]데칸-4-온 유도체 | |
| JP2011515462A5 (cg-RX-API-DMAC10.html) | ||
| AU2021242143B2 (en) | Aminopyrimidine derivatives and their use as Aryl hydrocarbon receptor modulators | |
| CN102482256B (zh) | N-取代的环状氨基衍生物 | |
| RU2006100190A (ru) | Производные хинолиламида в качестве антагонистов ccr-5 | |
| CN114907338B (zh) | 含氮多环稠环类化合物,其药物组合物、制备方法和用途 | |
| JPWO2019216294A5 (cg-RX-API-DMAC10.html) | ||
| KR20230051500A (ko) | Alk5 억제제로서 피리다진일 아미노 유도체 | |
| JP2023510971A (ja) | 新規複素環式化合物 | |
| JP2025509895A (ja) | Teaドメインファミリーメンバーの小分子阻害薬 | |
| JP2025513019A5 (cg-RX-API-DMAC10.html) | ||
| JP2023533807A5 (cg-RX-API-DMAC10.html) | ||
| JP2013522372A5 (cg-RX-API-DMAC10.html) |